FLT3 and neoplasm: Eventually, upon conducting a cell viability assay, compound 5 attenuated the tumor proliferation rate and improved the antiproliferation effect of Sorafenib on the human MV4-11 cells transplanted in mice with significant inhibition of the FLT3 and its downstream signaling in line with previously mentioned in vitro results.